Angelo Lombardo San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) IRCCS San Raffaele Scientific Institute Biography Publications Institution JoVE Articles Angelo Lombardo has not added a biography. If you are Angelo Lombardo and would like to personalize this page please email our Author Liaison for assistance. Publications Engineering of Immune Checkpoints B7-H3 and CD155 Enhances Immune Compatibility of MHC-I IPSCs for β Cell Replacement Cell Reports. Sep, 2022 | Pubmed ID: 36170817 Lentiviral Correction of Enzymatic Activity Restrains Macrophage Inflammation in Adenosine Deaminase 2 Deficiency Blood Advances. Aug, 2021 | Pubmed ID: 34424322 Deletion of a Pseudogene Within a Fragile Site Triggers the Oncogenic Expression of the Mitotic CCSER1 Gene Life Science Alliance. Aug, 2021 | Pubmed ID: 34187875 Altered Cl Homeostasis Hinders Forebrain GABAergic Interneuron Migration in a Mouse Model of Intellectual Disability Proceedings of the National Academy of Sciences of the United States of America. Jan, 2021 | Pubmed ID: 33376209 Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced and Genetic Engineering Molecular Therapy. Methods & Clinical Development. Dec, 2020 | Pubmed ID: 33294490 Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis Frontiers in Immunology. 2020 | Pubmed ID: 33013832 Gene Modification and Three-Dimensional Scaffolds As Novel Tools to Allow the Use of Postnatal Thymic Epithelial Cells for Thymus Regeneration Approaches Stem Cells Translational Medicine. Oct, 2019 | Pubmed ID: 31140762 T-cell Defects in Patients with Germline Mutations Account for Combined Immunodeficiency Blood. Nov, 2018 | Pubmed ID: 30254128 Therapeutic Gene Editing in CD34 Hematopoietic Progenitors from Fanconi Anemia Patients EMBO Molecular Medicine. Nov, 2017 | Pubmed ID: 28899930 Genome Editing for Scalable Production of Alloantigen-free Lentiviral Vectors for Gene therapy EMBO Molecular Medicine. Nov, 2017 | Pubmed ID: 28835507 IL-10-Engineered Human CD4 Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism Molecular Therapy : the Journal of the American Society of Gene Therapy. Oct, 2017 | Pubmed ID: 28807569 Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing Cell. Sep, 2016 | Pubmed ID: 27662090 Leukocytes Recruited by Tumor-derived HMGB1 Sustain Peritoneal Carcinomatosis Oncoimmunology. May, 2016 | Pubmed ID: 27467932 In Vitro (시험관 ) 표적 후성유전학적 침묵을 위한 엔지니어링된 전사 억제제 선택 Alessandro Migliara1, Martino Alfredo Cappelluti1, Francesca Giannese2, Sara Valsoni1, Alberto Coglot1, Ivan Merelli1,3, Davide Cittaro2, Angelo Lombardo1,4 1San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 2Center for Omics Sciences, IRCCS San Raffaele Institute, 3Institute for Biomedical Technologies, National Research Council, 4Vita-Salute San Raffaele University JoVE 64403 Bioengineering
In Vitro (시험관 ) 표적 후성유전학적 침묵을 위한 엔지니어링된 전사 억제제 선택 Alessandro Migliara1, Martino Alfredo Cappelluti1, Francesca Giannese2, Sara Valsoni1, Alberto Coglot1, Ivan Merelli1,3, Davide Cittaro2, Angelo Lombardo1,4 1San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 2Center for Omics Sciences, IRCCS San Raffaele Institute, 3Institute for Biomedical Technologies, National Research Council, 4Vita-Salute San Raffaele University JoVE 64403 Bioengineering
